Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 6 | |
Outperform | 8 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 13 analysts offering 12 month price targets for Denali Therapeutics Inc have a median target of 40.00, with a high estimate of 90.00 and a low estimate of 28.00. The median estimate represents a 65.15% increase from the last price of 24.22.
High | 271.6% | 90.00 |
Med | 65.2% | 40.00 |
Low | 15.6% | 28.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +1.99% |
Average growth rate | +25.22% |
More ▼
Revenue history & estimates in USD
Average growth rate | -25.00% |
Average growth rate | +350.06% |
More ▼